This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) rose 1.84% to $622.78 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.09% to 4,701.70 and the Dow Jones Industrial Average rising 0.29% to 36,432.22. The stock's rise snapped a two-day losing streak. Regeneron Pharmaceuticals Inc. closed $63.84 below its 52-week high ($686.62), which the company achieved on September 3rd.
The stock outperformed some of its competitors Monday, as Johnson & Johnson (JNJ) fell 0.34% to $162.87, Novartis AG ADR (NOVN.EB) fell 0.51% to $83.22, and Amgen Inc. (AMGN) fell 1.12% to $211.37. Trading volume (639,291) remained 153,250 below its 50-day average volume of 792,541.
Data source: Dow Jones Market Data, FactSet. Data compiled November 8, 2021.
(END) Dow Jones Newswires
November 08, 2021 17:19 ET (22:19 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.